Search Results Search Sort by RelevanceMost Recent Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487. Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519. Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last »
Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487.
Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519.
Case and Commentary Jul 2021 How Should Clinicians Minimize Harms and Maximize Benefits When Diagnosing and Treating Disorders Without Biomarkers? Benjamin Tolchin, MD, MS, Dorothy W. Tolchin, MD, EdM, and Michael Ashley Stein, JD, PhD Public and self-stigma negatively influence patients’ quality of life, employment, and housing opportunities. AMA J Ethics. 2021;23(7):E530-536. doi: 10.1001/amajethics.2021.530.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.